1. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?. (16th October 2017) Authors: Nestor, L.; Clowry, J.; Molloy, K.; Connolly, M.; Salim, A.; Tobin, A. M. Journal: Clinical and experimental dermatology Issue: Volume 42:Number 8(2017) Page Start: 945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?. (1st December 2017) Authors: Nestor, L.; Clowry, J.; Molloy, K.; Connolly, M.; Salim, A.; Tobin, A. M. Journal: Clinical and experimental dermatology Issue: Volume 42:Number 8(2017) Page Start: 945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The treatment of hidradenitis suppurativa with the glucagon‐like peptide‐1 agonist liraglutide. (14th July 2017) Authors: Jennings, L.; Nestor, L.; Molloy, O.; Hughes, R.; Moriarty, B.; Kirby, B. Journal: British journal of dermatology Issue: Volume 177:Number 3(2017) Page Start: 858 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The treatment of hidradenitis suppurativa with the glucagon‐like peptide‐1 agonist liraglutide. (1st September 2017) Authors: Jennings, L.; Nestor, L.; Molloy, O.; Hughes, R.; Moriarty, B.; Kirby, B. Journal: British journal of dermatology Issue: Volume 177:Number 3(2017) Page Start: 858 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗